Navigation Links
FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
Date:6/26/2012

Richmond, BC, Canada (PRWEB) June 26, 2012

Ultrasonix Medical Corporation has received approval from the US Food and Drug Administration for its SonixGPS technology for Vascular Access procedures.

First approved for use in Canada, the SonixGPS technology has been used in hospitals in British Columbia and Ontario since October 2011. Clinical studies have proven the accuracy and clinical benefits of using the new technology for guidance procedures such as nerve blocks for regional anesthesia and pain management and vascular access procedures. The guidance technology is also useful for difficult biopsies, aspirations and placement of therapeutic agents.

“My experience using GPS in a teaching environment has shown that both junior and senior clinicians are quite taken by the power of the GPS to convey the sense of needle localization on screen, both before you enter the tissue and once you achieve the exact plane at which you want to pass a guide wire for central venous cannulation,” said Dr. Brian Pollard.

SonixGPS helps clearly predict and see the needle’s trajectory during invasive procedures. Unlike other guidance technologies, SonixGPS enables clinicians to position the transducer in the ideal location to see the target and to select a needle direction and angle that is safest and most comfortable for the patient. It always shows the predicted trajectory and true path of the needle in real time. Needle adjustments are reflected instantly on the display.

“Our SonixGPS technology exemplifies our company’s focus on innovation, guidance and simplicity. We are delighted to have regulatory approvals in key global areas,” said Laurent Pelissier, Founder and Chief Executive Officer of Ultrasonix. “We believe our guidance technology can improve patient safety and save physicians valuable time. We look forward to expanding its footprint.”

SonixGPS has received CE Mark for both nerve blocks and vascular access. SonixGPS for nerve block procedures is pending FDA 510(k). The SonixGPS option is available on the SonixTouch, SonixTablet and SonixMDP ultrasound systems.

About Ultrasonix
Ultrasonix develops and manufactures diagnostic ultrasound imaging systems with customizable touch screens to simplify workflows. The company's systems are built on an open software platform that enables remote service and easy updates to keep current with advancements in imaging technology. Founded in 2000, Ultrasonix is a privately-held company headquartered in Richmond, British Columbia, Canada. http://www.ultrasonix.com/gps.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9640545.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. FDA Approves Combo Shot for Meningitis, Hib in Kids
2. FDA Approves Generic Versions of Plavix
3. For Juvenile Arthritis, Pill May Work as Well as Needle
4. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
5. Swanson Health Products Introduces a New Alkalizing Drink Mix, Swanson® pH Balance Alka-Tone with Alka-Plex™ Technology
6. The Casey Group's Sales Navigator Wins 2012 Best Mobility App in the New Jersey Technology Council's Mobile Application Competition
7. Simulation technology allows users to safely practice phacoemulsification cataract surgery
8. Power generation technology based on piezoelectric nanocomposite materials developed by KAIST
9. New study identifies how information technology is used to solve global health challenges
10. Mechanical tissue resuscitation technology shows promise
11. Low steroid levels linked to increased risk of cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided ... Piedras, Puerto Rico , where the ... Following a comprehensive onsite ... structural damage, temporary loss of power and minimal water ... manufacturing operations have resumed, and the company expects to ...
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: